Fremanezumab (AJOVY®) now available within NHS Scotland 13 January 2020

The Scottish Medicines Consortium (SMC) announced today that fremanezumab (Ajovy®) has been accepted for a restricted use within NHS Scotland for the prevention of migraine in adults who have at least four migraine days per month. We welcome this news and Dr David Bloomfield CEO of National Migraine Centre said: ”We are pleased that the […]



Research Project into Psychological Factors in Migraine 16 December 2019

The Centre for Pain Research and National University of Ireland, Galway (NUI Galway) are conducting a research project in Ireland and the UK into psychological factors in migraine. The research is intended to help develop better therapies to help people manage their migraine. The study is open to adults with migraine in Ireland and the UK who have seen a health professional for their migraine. The study involves a one-off online survey with 11 questionnaires, […]



Christmas Message from the CEO 16 December 2019

Dear All, As we approach the end of this year, I want to thank our brilliant doctors, the admin team and our fantastic volunteers and supporters for their hard work and dare I say it, ‘infectious’ spirit. I also want to thank all the patients who have contributed to our various fundraising campaigns and helped […]